Target intelligence / Profile preview

VASH1 divergent transcript (VASH1-DT)

Target: VASH1-DT
Molecular classification: Other

Overview

VASH1 divergent transcript (VASH1-DT) is annotated as a non-coding RNA located in proximity to the Vasohibin 1 gene. The term "divergent transcript" typically refers to transcripts produced from regions adjacent to protein-coding genes, often running in the opposite direction, but does not indicate coding potential or functional activity[3]. There is no published evidence that VASH1-DT encodes a functional protein, acts as a receptor, enzyme, or transporter, or serves as a therapeutic target. All existing molecular, biological, and disease data relate to VASH1 protein, which regulates angiogenesis, tubulin detyrosination, and is implicated in cancer and kidney disease[4][5]. The functional relevance of VASH1-DT is currently unknown.

Other names: VASH1-DTVASH1 divergent transcript

Beyond the preview

Go deeper on VASH1 divergent transcript (VASH1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VASH1 divergent transcript (VASH1-DT).

Explore the full profile